Related Experiment Video
Updated: Sep 27, 2026
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
[Effect of lanreotide on prolactin level in patients with pituitary mixed tumors]
R Wasko1, J Sawicka, C Stachowiak
1Clinique d'Endocrinologie, Académie de Médecine de l'Université de Karol Marcinkowski de Poznan 60-355. Przybyszewskiego 49, Pologne.
Abstract:
Acromegaly is a disease caused by a pituitary tumor (somatotropinoma) or by ectopic secretion of GH or IGF-1. About 15% of tumors secrete not only GH but PRL as well. Last time a lanreotide and an octreotide (the somatostatine analogues) are useful in the therapy of acromegaly. We observed the influence of the lanreotide on GH and prolactin. We noticed that the lanreotide caused not only serum level reduction of a growth hormone but also prolactine in patients with mixed pituitary tumors.
